Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory P Geba

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 17, 2008
Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysisRobert J Maykut, Farid Kianifard, Gregory P Geba
Current Medical Research and Opinion|August 23, 2007
Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysisWilliam W Busse, Marc Massanari, Farid Kianifard, et al.
Allergy and Asthma Proceedings|May 27, 2009
Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthmaMarc Massanari, Farid Kianifard, Robert K Zeldin, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
Advances in Therapy|May 7, 2021
A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the USWenhui Wei, Sumathi Sivapalasingam, Scott Mellis, et al.
Pediatric Transplantation|August 13, 2009
Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host diseaseJoel A Brochstein, Stephan Grupp, Harry Yang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 7, 2010
Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthmaJill Karpel, Marc Massanari, Gregory P Geba, et al.
Current Medical Research and Opinion|December 8, 2009
Association between incidence of acute exacerbation and medication therapy in patients with COPDDong-Churl Suh, Helen Lau, Hyen-Oh La, et al.
Cancer Medicine|November 29, 2022
Serum cholesterol and the risk of developing hormonally driven cancers: A narrative reviewDana J Murdock, Robert J Sanchez, Kusha A Mohammadi, et al.
Journal of Lipid Research|May 25, 2024
Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infectionKusha Mohammadi, Mark W Sleeman, Anita Boyapati, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 17, 2008
Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysisRobert J Maykut, Farid Kianifard, Gregory P Geba
Current Medical Research and Opinion|August 23, 2007
Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysisWilliam W Busse, Marc Massanari, Farid Kianifard, et al.
Allergy and Asthma Proceedings|May 27, 2009
Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthmaMarc Massanari, Farid Kianifard, Robert K Zeldin, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
Advances in Therapy|May 7, 2021
A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the USWenhui Wei, Sumathi Sivapalasingam, Scott Mellis, et al.
Pediatric Transplantation|August 13, 2009
Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host diseaseJoel A Brochstein, Stephan Grupp, Harry Yang, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 7, 2010
Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthmaJill Karpel, Marc Massanari, Gregory P Geba, et al.
Current Medical Research and Opinion|December 8, 2009
Association between incidence of acute exacerbation and medication therapy in patients with COPDDong-Churl Suh, Helen Lau, Hyen-Oh La, et al.
Cancer Medicine|November 29, 2022
Serum cholesterol and the risk of developing hormonally driven cancers: A narrative reviewDana J Murdock, Robert J Sanchez, Kusha A Mohammadi, et al.
Journal of Lipid Research|May 25, 2024
Effect of IL-6R blockade on plasma lipids and clinical outcomes among hospitalized patients with COVID-19 infectionKusha Mohammadi, Mark W Sleeman, Anita Boyapati, et al.
Pageof 7